The race to develop the best transcatheter mitral replacement valve technology continues to heat-up with Medtronic's $458m acquisition of Twelve, Inc.
Medtronic will pay $408m up-front for privately held Twelve, plus another $50m when a transcatheter mitral valve based on its...





